Spearheaded by Vice President Joseph Biden, the White House Cancer Moonshot Task Force was created to double the rate of progress in cancer research and treatment, striving to accelerate what could be achieved in ten years in just five. Earlier this week, Vice President Joe Biden delivered the Cancer Moonshot Report to the President and the American public in the Oval Office. The report summarizes the work of the Cancer Moonshot Task Force and lays out the Vice President’s strategic plan for transforming cancer research and care. The report also included the announcement of new commitments toward the goals of the Cancer Moonshot from both public and private sectors and CANCER101 was honored to have been recognized, among others, in this effort.
In alignment with the goals of the White House’s Cancer Moonshot Initiative to advance clinical progress, CANCER101 launched Prescription to Learn® (P2L), an interactive platform co-created with patients and caregivers to address the growing problem of information overload. P2L is the “health GPS” to curated resources and solutions to issues patients and caregivers face in navigating health information to make informed decisions. Through P2L, patients and caregivers can personalize their search for information and support, access resources aligned with learning style preference, and view resource ratings from other patients, caregivers, and clinicians.
‘Where do I start?’ is a question we often hear from newly diagnosed patients and their families, who are inundated with a tsunami of information during a time they need to make life-altering decisions expeditiously. Prescription to Learn was co-created with patients and caregivers to guide them through information from credible sources, allow them to personalize the educational journey based on their preferences, and empower them with the information they need to alleviate fear of the unknown. With answers to their questions and facts at their fingertips, they can focus on what’s most important—their health and well-being. We are honored that our collaborative intervention was highlighted by the White House’s Cancer Moonshot Taskforce, spearheaded by Vice President Joseph Biden, and we are proud to join others in accelerating progress to end cancer as we know it.
Developed and launching in partnership with several hospitals, patient advocacy organizations and medical education providers, including University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Perlmutter Cancer Center at NYU Langone, Mayo Clinic, and the Health Collaboratory, P2L will launch in four tumor types, expand to other cancers and conditions beyond cancer in 2017, and will be integrated into medical education curriculum for clinicians nationwide, with plans to expand globally and to other disease states over time. With touch points at over 1,200 hospitals and community practices, hundreds of patient advocacy organizations, and numerous medical education providers, P2L will empower and encourage patients and their caregivers to take control over their diagnosis and partner with their healthcare team to make more informed medical decisions. P2L will continuously evolve based on needs and YOUR feedback, thus please tell us what you think!
Great post! Thanks for sharing this article.